Genetic Markers Linked to Neurological COVID Risks in North America

A new study from researchers at St. Petersburg Polytechnic University and the Ufa University of Science and Technology identifies genetic markers linked to neurological complications in COVID-19. The findings, reported to the Ministry of Education and Science, open the door to clinical tests that can identify people at higher risk for lasting nervous system effects from the virus. The work provides a pathway for early intervention and personalized care for patients diagnosed with COVID-19 in Canada and the United States.